Stocktoria
BIOLIFE SOLUTIONS INC BLFS
BIOLIFE SOLUTIONS INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $96.2M | $74.6M | $68.0M | $76.2M | $119.2M | $48.1M | $27.4M | $19.7M | $11.0M | — |
| Gross profit | $62.1M | $50.1M | $41.3M | — | — | — | — | $13.5M | $6.7M | $4.8M |
| R&D expense | $7.6M | $4.8M | $5.5M | $8.7M | $11.8M | $6.7M | $3.2M | $1.3M | $1.2M | $2.0M |
| Operating income | -$16.6M | -$4.5M | -$17.2M | -$5.9M | -$35.2M | -$6.2M | -$220,000 | $3.7M | -$1.1M | -$4.9M |
| Interest expense | — | — | — | — | — | — | $5,000 | $5,000 | $190,000 | $100,000 |
| Income tax | $49,000 | -$38,000 | -$64,000 | -$5.2M | -$20.1M | -$3.3M | -$1.5M | — | $0 | $0 |
| Net income | -$4.6M | -$20.2M | -$68.0M | -$139.8M | -$8.9M | $2.0M | -$1.7M | -$25.0M | -$2.5M | -$6.9M |
| EPS (diluted) | $-0.10 | $-0.44 | $-1.55 | $-3.25 | $-0.23 | $-0.06 | $-0.09 | $-1.56 | $-0.21 | — |
| Operating cash flow | $20.1M | $8.4M | -$12.5M | -$8.5M | -$4.6M | $6.6M | $1.2M | $2.3M | $605,000 | -$4.3M |
| Free cash flow | $10.6M | $5.2M | -$18.9M | -$18.9M | -$13.0M | $4.7M | $538,000 | $1.8M | $461,000 | -$4.5M |
| Cash & equivalents | $33.0M | $91.5M | $27.9M | $19.4M | $69.9M | $90.4M | $6.4M | $30.7M | $6.7M | $1.4M |
| Inventory | $30.2M | $29.0M | $27.2M | $34.9M | $28.3M | $11.6M | $11.0M | $3.5M | $1.8M | $1.8M |
| Total assets | $405.9M | $399.5M | $412.7M | $450.2M | $554.3M | $234.8M | $92.8M | $45.5M | $12.1M | $7.9M |
| Total liabilities | $34.0M | $50.6M | $75.1M | $86.0M | $76.2M | $29.6M | $49.4M | $30.8M | $2.1M | $4.8M |
| Shareholders' equity | $371.9M | $348.9M | $337.7M | $364.2M | $478.0M | $204.4M | $43.3M | $14.6M | $10.1M | $3.2M |
Growth · year-over-year · Revenue CAGR 31.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +28.9% | +9.7% | -10.8% | -36.0% | +147.8% | +75.7% | +38.6% | +79.1% | — | — |
| Net income growth | — | — | — | — | -549.2% | — | — | — | — | — |
| Free cash flow growth | +104.4% | — | — | — | -377.1% | +770.6% | -70.9% | +300.9% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.